share_log

Safety Shot | CORRESP: CORRESP

SEC ·  Feb 6 03:00

Summary by Futu AI

Safety Shot, Inc. has submitted a response to the Securities and Exchange Commission (SEC) addressing comments from the SEC's letter dated February 1, 2024, regarding Post-Effective Amendment No. 5 on Form S-1 filed on January 23, 2024. The company clarified discrepancies in its disclosures, particularly around the classification and regulatory requirements of its products, including JW-500, JW-700, Photocil, and Safety Shot Beverage. Safety Shot, Inc. has updated its Registration Statement to reflect these clarifications and to remove any statements of safety and efficacy for products not approved by the FDA or similar foreign regulators. The company also provided additional information on the commercialization status of its products, including the markets where they are sold and their development stages. Furthermore, Safety Shot, Inc. outlined...Show More
Safety Shot, Inc. has submitted a response to the Securities and Exchange Commission (SEC) addressing comments from the SEC's letter dated February 1, 2024, regarding Post-Effective Amendment No. 5 on Form S-1 filed on January 23, 2024. The company clarified discrepancies in its disclosures, particularly around the classification and regulatory requirements of its products, including JW-500, JW-700, Photocil, and Safety Shot Beverage. Safety Shot, Inc. has updated its Registration Statement to reflect these clarifications and to remove any statements of safety and efficacy for products not approved by the FDA or similar foreign regulators. The company also provided additional information on the commercialization status of its products, including the markets where they are sold and their development stages. Furthermore, Safety Shot, Inc. outlined the regulatory categories for its products under FDA guidelines, specifying that Photocil, JW-500, and JW-700 are classified as cosmetic products, while Safety Shot Beverage is classified as a dietary supplement. The company also addressed a lawsuit involving GBB Lab, Inc., a subsidiary formed to acquire assets related to the Safety Shot Beverage, stating that the outcome of the litigation is not material to the company's business. The response included a request for a call with the SEC to ensure all comments have been satisfactorily addressed.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.